{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:42:53Z","timestamp":1793083373574,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":1735,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","award":["PHRC 2008-N11-01"],"award-info":[{"award-number":["PHRC 2008-N11-01"]}],"id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1017\/s1041610219000358","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T05:42:58Z","timestamp":1557207778000},"page":"441-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Benzodiazepine use among older adults with schizophrenia spectrum disorder: prevalence and associated factors in a multicenter study"],"prefix":"10.1016","volume":"32","author":[{"given":"Jean-Pierre","family":"Schuster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Hoertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"von Gunten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Seigneurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Limosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610219000358_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11920-016-0727-9","article-title":"Benzodiazepine misuse in the elderly: Risk factors, consequences, and management","volume":"18","author":"Airagnes","year":"2016","journal-title":"Current Psychiatry Reports"},{"key":"10.1017\/S1041610219000358_bb0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.psychres.2019.03.036","article-title":"Metabolic syndrome among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study","volume":"275","author":"Abou Kassm","year":"2019","journal-title":"Psychiatry Research"},{"key":"10.1017\/S1041610219000358_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00406-016-0711-8","article-title":"Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo","volume":"267","author":"Baandrup","year":"2017","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1017\/S1041610219000358_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/YCO.0b013e32835d9efb","article-title":"Polypharmacy for schizophrenia","volume":"26","author":"Ballon","year":"2013","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1017\/S1041610219000358_bb0035","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1176\/appi.ps.54.10.1395","article-title":"Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders","volume":"54","author":"Brunette","year":"2003","journal-title":"Psychiatric Services"},{"key":"10.1017\/S1041610219000358_bb0040","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1176\/ps.2006.57.8.1094","article-title":"Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial","volume":"57","author":"Chakos","year":"2006","journal-title":"Psychiatric Services"},{"key":"10.1017\/S1041610219000358_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4088\/JCP.v65n0202","article-title":"Benzodiazepine prescription practices and substance abuse in persons with severe mental illness","volume":"65","author":"Clark","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0050","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S2215-0366(15)00003-6","article-title":"New perspectives on schizophrenia in later life: implications for treatment, policy, and research","volume":"2","author":"Cohen","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2017.06.022","article-title":"A prospective analysis of the role of cognition in three models of aging and schizophrenia","volume":"196","author":"Cohen","year":"2018","journal-title":"Schizophrenia Research"},{"key":"10.1017\/S1041610219000358_bb0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/ps.2008.59.3.232","article-title":"Schizophrenia in later life: clinical symptoms and social well-being","volume":"59","author":"Cohen","year":"2008","journal-title":"Psychiatric Services"},{"key":"10.1017\/S1041610219000358_bb0065","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jagp.2017.01.013","article-title":"A longitudinal analysis of quality of life and associated factors in older adults with schizophrenia spectrum disorder","volume":"25","author":"Cohen","year":"2017","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0070","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0920-9964(98)00161-3","article-title":"Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes","volume":"35","author":"Dixon","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1017\/S1041610219000358_bb0075","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.euroneuro.2013.03.001","article-title":"Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials","volume":"23","author":"Dold","year":"2013","journal-title":"European Neuropsychopharmacology"},{"key":"10.1017\/S1041610219000358_bb0080","first-page":"CD006391","article-title":"Benzodiazepines for schizophrenia","volume":"11","author":"Dold","year":"2012","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S1041610219000358_bb0085","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0090","first-page":"CD004162","article-title":"Antipsychotic drug treatment for elderly people with late-onset schizophrenia","volume":"15","author":"Essali","year":"2012","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S1041610219000358_bb0095","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.1984.03350140051025","article-title":"Detecting alcoholism. The CAGE questionnaire","volume":"252","author":"Ewing","year":"1984","journal-title":"JAMA"},{"key":"10.1017\/S1041610219000358_bb0100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4088\/JCP.15m10271","article-title":"Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study","volume":"77","author":"Fontanella","year":"2016","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002018-199921020-00004","article-title":"Drug-induced cognition disorders in the elderly: incidence, prevention and management","volume":"21","author":"Gray","year":"1999","journal-title":"Drug Safety"},{"key":"10.1017\/S1041610219000358_bb0110","first-page":"3","article-title":"Cognitive impairment and functional outcome in schizophrenia and bipolar disorder","volume":"67","author":"Green","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0115","first-page":"76","article-title":"Clinical global impression","author":"Guy","year":"1976"},{"key":"10.1017\/S1041610219000358_bb0120","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0269881106072386","article-title":"Benzodiazepines\u2014a necessary evil? A survey of prescribing at a specialist UK psychiatric hospital","volume":"21","author":"Haw","year":"2007","journal-title":"Journal of Psychopharmacology"},{"key":"10.1017\/S1041610219000358_bb0125","doi-asserted-by":"crossref","first-page":"M693","DOI":"10.1093\/gerona\/56.11.M693","article-title":"Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging","volume":"56","author":"Hebert","year":"2001","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1017\/S1041610219000358_bb0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The quality of life scale: an instrument for rating the schizophrenic deficit syndrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophrenia Bulletin"},{"key":"10.1017\/S1041610219000358_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.psychres.2017.02.023","article-title":"The psychometric validity of the Center for Epidemiological Studies Depression Scale (CES-D) in first episode schizophrenia spectrum","volume":"252","author":"Herniman","year":"2017","journal-title":"Psychiatry Research"},{"key":"10.1017\/S1041610219000358_bb0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eurpsy.2013.12.001","article-title":"Poor longitudinal continuity of care is associated with an increased mortality rate among patients with mental disorders: results from the French National Health Insurance Reimbursement Database","volume":"29","author":"Hoertel","year":"2014","journal-title":"European Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2019.03.007","article-title":"Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study","volume":"251","author":"Hoertel","year":"2019","journal-title":"Journal of Affective Disorders"},{"key":"10.1017\/S1041610219000358_bb0150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/appi.ajp.157.2.172","article-title":"Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group.","volume":"157","author":"Howard","year":"2000","journal-title":"The American Journal of Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eurpsy.2017.06.004","article-title":"Lifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland Birth Cohort 1966","volume":"45","author":"Hulkko","year":"2017","journal-title":"European Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0160","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.166.5.654","article-title":"A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF)","volume":"166","author":"Jones","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0165","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1742-1241.2009.02191.x","article-title":"Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients","volume":"63","author":"Karagianis","year":"2009","journal-title":"International Journal of Clinical Practice"},{"key":"10.1017\/S1041610219000358_bb0170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pnpbp.2011.11.008","article-title":"Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic","volume":"36","author":"Kitajima","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0175","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.1994.03520220076034","article-title":"Does this patient have an alcohol problem?","volume":"272","author":"Kitchens","year":"1994","journal-title":"JAMA"},{"key":"10.1017\/S1041610219000358_bb0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00801903","article-title":"Measures of quality of life among persons with severe and persistent mental disorders","volume":"31","author":"Lehman","year":"1996","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1017\/S1041610219000358_bb0185","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"Lembke","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1017\/S1041610219000358_bb0190","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1360-0443.2011.03547.x","article-title":"Correlation is no causation: gymnasium proliferation and the risk of obesity","volume":"106","author":"Le Strat","year":"2011","journal-title":"Addiction"},{"key":"10.1017\/S1041610219000358_bb0195","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0200","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.159.6.975","article-title":"Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers","volume":"159","author":"Liu","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0205","first-page":"CD005580","article-title":"Antipsychotic medication for elderly people with schizophrenia","volume":"25","author":"Marriott","year":"2006","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S1041610219000358_bb0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jad.2018.09.072","article-title":"Diet and physical activity in the association between depression and metabolic syndrome: Constances study","volume":"244","author":"Matta","year":"2019","journal-title":"Journal of Affective Disorders"},{"key":"10.1017\/S1041610219000358_bb0215","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jagp.2015.09.003","article-title":"Mortality and its determinants in late-life schizophrenia: a 5-year prospective study in a Dutch catchment area","volume":"24","author":"Meesters","year":"2016","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jagp.2012.10.008","article-title":"The care needs of elderly patients with schizophrenia spectrum disorders","volume":"21","author":"Meesters","year":"2013","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0225","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.respe.2011.03.061","article-title":"Psychometric properties of the Center for Epidemiologic Studies Depression Scale (CES-D) in French clinical and nonclinical adults","volume":"59","author":"Morin","year":"2011","journal-title":"Revue d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique"},{"key":"10.1017\/S1041610219000358_bb0230","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.pnpbp.2005.06.003","article-title":"Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study","volume":"29","author":"Novick","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1017\/S1041610219000358_bb0240","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Applied Psychological Measurement"},{"key":"10.1017\/S1041610219000358_bb0245","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1017\/S1041610215001064","article-title":"Mental healthcare in older adults with schizophrenia: results from 118 French public psychiatric departments","volume":"27","author":"Raucher-Ch\u00e9n\u00e9","year":"2015","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610219000358_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0022-3956(75)90021-7","article-title":"Measurement of appetite disturbances in psychiatric disorders","volume":"12","author":"Robinson","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1017\/S1041610219000358_bb0255","series-title":"Analysis of Incomplete Multivariate Data","author":"Schafer","year":"1997"},{"key":"10.1017\/S1041610219000358_bb0260","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0269881114541013","article-title":"Re-examining the role of benzodiazepines in the treatment of schizophrenia: a systematic review","volume":"29","author":"Sim","year":"2015","journal-title":"Journal of Psychopharmacology"},{"key":"10.1017\/S1041610219000358_bb0265","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"10.1017\/S1041610219000358_bb0270","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","article-title":"Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study","volume":"173","author":"Tiihonen","year":"2016","journal-title":"The American Journal of Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0275","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00406-006-0693-z","article-title":"The current state of adult mental health care in France","volume":"257","author":"Verdoux","year":"2007","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1017\/S1041610219000358_bb0280","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00127-002-0553-8","article-title":"Substance abuse in schizophrenia: a Singapore perspective","volume":"37","author":"Verma","year":"2002","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1017\/S1041610219000358_bb0285","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m12003","article-title":"Depression, cognitive functions, and impaired functioning in middle-aged adults from the CONSTANCES cohort","volume":"79","author":"Vulser","year":"2018","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0290","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3945\/ajcn.113.068122","article-title":"BMI and all-cause mortality in older adults: a meta-analysis","volume":"99","author":"Winter","year":"2014","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1017\/S1041610219000358_bb0295","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610219000358_bb0300","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1176\/ps.62.8.pss6208_0908","article-title":"Benzodiazepine use among patients with schizophrenia in Taiwan: a nationwide population-based survey","volume":"62","author":"Wu","year":"2011","journal-title":"Psychiatric Services"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224024955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224024955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610219000358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:02:11Z","timestamp":1754978531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224024955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1041610224024955"],"URL":"https:\/\/doi.org\/10.1017\/s1041610219000358","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepine use among older adults with schizophrenia spectrum disorder: prevalence and associated factors in a multicenter study","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610219000358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}